JosephAndrewMollickMD

Breast Cancer, Hematologic Oncology

Staff Physician, Medicine - Oncology, Stanford University Medical Center

Dr. Mollick is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1900 Sullivan Aveune
Lower Level
Daly City, CA 94015
Phone+1 650-991-5800

Fax+1 650-991-6385

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2001 - 2005
Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1996
Baylor College of MedicineClass of 1994

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

PubMed

3 citations
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
Holbrook E Kohrt, Roch Houot, Kipp Weiskopf, Matthew J Goldstein, Ferenc Scheeren
The Journal of Clinical Investigation. 2019-06-03
190 citations
A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
Susan M. Hiniker, Daniel S. Chen, Sunil Reddy, Daniel T. Chang, Jennifer Jones
Translational Oncology. 2012-12-01
29 citations
Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1
Pearline Zhaoying Teo, Paul J. Utz, Joseph A. Mollick
Cancer Immunology, Immunotherapy. 2012-06-13

Using The Allergic Immune System To Target CancerNational Cancer Institute2006–2009
Muc1-Like Proteins In Cancer ImmunotherapyNational Cancer Institute2005
Activity Of Breast Cancer Associated AntigenNational Cancer Institute2000–2003
Activity Of Breast Cancer Associated AntigenNational Cancer Institute1998–2000